Loading...

Plant Advanced Technologies

ENXTPA:ALPAT
Snowflake Description

Imperfect balance sheet with concerning outlook.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ALPAT
ENXTPA
€16M
Market Cap
  1. Home
  2. FR
  3. Pharmaceuticals & Biotech
Company description

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. The last earnings update was 172 days ago. More info.


Add to Portfolio Compare Print
ALPAT Share Price and Events
7 Day Returns
-4.1%
ENXTPA:ALPAT
-1.7%
FR Biotechs
1.3%
FR Market
1 Year Returns
-26.4%
ENXTPA:ALPAT
-33.2%
FR Biotechs
3.6%
FR Market
ALPAT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Plant Advanced Technologies (ALPAT) -4.1% 5.9% -8.5% -26.4% -18.6% -37.7%
FR Biotechs -1.7% 0.3% 1.6% -33.2% -56.9% -39.9%
FR Market 1.3% 3.8% 14.3% 3.6% 28.9% 33.6%
1 Year Return vs Industry and Market
  • ALPAT outperformed the Biotechs industry which returned -33.2% over the past year.
  • ALPAT underperformed the Market in France which returned 3.6% over the past year.
Price Volatility
ALPAT
Industry
5yr Volatility vs Market

Value

 Is Plant Advanced Technologies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Plant Advanced Technologies. This is due to cash flow or dividend data being unavailable. The share price is €16.2.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Plant Advanced Technologies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Plant Advanced Technologies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ENXTPA:ALPAT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in EUR €-0.73
ENXTPA:ALPAT Share Price ** ENXTPA (2019-04-18) in EUR €16.2
France Biotechs Industry PE Ratio Median Figure of 7 Publicly-Listed Biotechs Companies 15.51x
France Market PE Ratio Median Figure of 418 Publicly-Listed Companies 16.34x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Plant Advanced Technologies.

ENXTPA:ALPAT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:ALPAT Share Price ÷ EPS (both in EUR)

= 16.2 ÷ -0.73

-22.12x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Plant Advanced Technologies is loss making, we can't compare its value to the FR Biotechs industry average.
  • Plant Advanced Technologies is loss making, we can't compare the value of its earnings to the France market.
Price based on expected Growth
Does Plant Advanced Technologies's expected growth come at a high price?
Raw Data
ENXTPA:ALPAT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -22.12x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
-19.3%per year
France Biotechs Industry PEG Ratio Median Figure of 6 Publicly-Listed Biotechs Companies -0.08x
France Market PEG Ratio Median Figure of 273 Publicly-Listed Companies 1.51x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Plant Advanced Technologies, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Plant Advanced Technologies's assets?
Raw Data
ENXTPA:ALPAT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in EUR €7.00
ENXTPA:ALPAT Share Price * ENXTPA (2019-04-18) in EUR €16.2
France Biotechs Industry PB Ratio Median Figure of 32 Publicly-Listed Biotechs Companies 2.14x
France Market PB Ratio Median Figure of 619 Publicly-Listed Companies 1.49x
ENXTPA:ALPAT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:ALPAT Share Price ÷ Book Value per Share (both in EUR)

= 16.2 ÷ 7.00

2.32x

* Primary Listing of Plant Advanced Technologies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Plant Advanced Technologies is overvalued based on assets compared to the FR Biotechs industry average.
X
Value checks
We assess Plant Advanced Technologies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Biotechs industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Biotechs industry average (and greater than 0)? (1 check)
  5. Plant Advanced Technologies has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Plant Advanced Technologies expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-19.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Plant Advanced Technologies expected to grow at an attractive rate?
  • Unable to compare Plant Advanced Technologies's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Plant Advanced Technologies's earnings growth to the France market average as it is expected to be loss making during the next 1-3 years.
  • Plant Advanced Technologies's revenue growth is expected to exceed the France market average.
Annual Growth Rates Comparison
Raw Data
ENXTPA:ALPAT Future Growth Rates Data Sources
Data Point Source Value (per year)
ENXTPA:ALPAT Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts -19.3%
ENXTPA:ALPAT Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 11.2%
France Biotechs Industry Earnings Growth Rate Market Cap Weighted Average 14.9%
France Biotechs Industry Revenue Growth Rate Market Cap Weighted Average 31.8%
France Market Earnings Growth Rate Market Cap Weighted Average 13.4%
France Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ENXTPA:ALPAT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ENXTPA:ALPAT Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 2 -1 1
2019-12-31 1 -2 1
2018-12-31 1 -2 1
ENXTPA:ALPAT Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-06-30 2 -1
2018-03-31 2 -1
2017-12-31 1 0 -1
2017-09-30 2 -1
2017-06-30 2 1 0
2017-03-31 2 1 -1
2016-12-31 2 0 -1
2016-09-30 2 -1
2016-06-30 2 -1 -2
2016-03-31 2 -1 -1
2015-12-31 2 -1 -1
2015-09-30 2 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Plant Advanced Technologies is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Plant Advanced Technologies's revenue is expected to grow by 11.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ENXTPA:ALPAT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Plant Advanced Technologies Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ENXTPA:ALPAT Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 -1.31 -1.31 -1.31 1.00
2019-12-31 -1.73 -1.73 -1.73 1.00
2018-12-31 -1.52 -1.52 -1.52 1.00
ENXTPA:ALPAT Past Financials Data
Date (Data in EUR Millions) EPS *
2018-06-30
2018-03-31
2017-12-31 -0.73
2017-09-30 -0.62
2017-06-30
2017-03-31
2016-12-31 -1.25
2016-09-30
2016-06-30
2016-03-31
2015-12-31 -0.99
2015-09-30 -0.85

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Plant Advanced Technologies will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Plant Advanced Technologies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the France market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the France market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Plant Advanced Technologies has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Plant Advanced Technologies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Plant Advanced Technologies's growth in the last year to its industry (Biotechs).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Plant Advanced Technologies does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Plant Advanced Technologies's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Plant Advanced Technologies's 1-year growth to the Europe Biotechs industry average as it is not currently profitable.
Earnings and Revenue History
Plant Advanced Technologies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Plant Advanced Technologies Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ENXTPA:ALPAT Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 1.73 -0.53 1.88
2018-03-31 1.60 -0.60 1.89
2017-12-31 1.46 -0.67 1.90
2017-09-30 1.59 -0.57 1.87
2017-06-30 1.71 -0.46 1.84
2017-03-31 1.64 -0.79 1.78
2016-12-31 1.58 -1.13 1.72
2016-09-30 1.55 -1.33 1.67
2016-06-30 1.52 -1.54 1.63
2016-03-31 1.70 -1.22 1.55
2015-12-31 1.88 -0.89 1.47
2015-09-30 1.84 -0.75 1.40
2015-06-30 1.79 -0.60 1.33
2015-03-31 1.74 -0.60 1.27
2014-12-31 1.68 -0.59 1.20
2014-09-30 1.64 -0.45 1.13
2014-06-30 1.59 -0.30 1.06
2014-03-31 1.58 -0.18 1.05
2013-12-31 1.57 -0.07 1.03

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Plant Advanced Technologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Plant Advanced Technologies has efficiently used its assets last year compared to the FR Biotechs industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Plant Advanced Technologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Plant Advanced Technologies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Biotechs industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Plant Advanced Technologies has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Plant Advanced Technologies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Plant Advanced Technologies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Plant Advanced Technologies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Plant Advanced Technologies's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Plant Advanced Technologies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Plant Advanced Technologies Company Filings, last reported 9 months ago.

ENXTPA:ALPAT Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 5.95 3.66 0.25
2018-03-31 5.95 3.66 0.25
2017-12-31 6.41 2.24 0.05
2017-09-30 6.41 2.24 0.05
2017-06-30 5.98 2.24 0.95
2017-03-31 5.98 2.24 0.95
2016-12-31 6.59 1.94 1.25
2016-09-30 6.59 1.94 1.25
2016-06-30 6.44 2.55 2.63
2016-03-31 6.44 2.55 2.63
2015-12-31 7.71 2.06 3.24
2015-09-30 7.71 2.06 3.24
2015-06-30 7.99 1.90 5.04
2015-03-31 7.99 1.90 5.04
2014-12-31 2.35 2.29 0.09
2014-09-30 2.35 2.29 0.09
2014-06-30 2.33 1.36 0.09
2014-03-31 2.33 1.36 0.09
2013-12-31 2.10 1.43 0.07
  • Plant Advanced Technologies's level of debt (61.4%) compared to net worth is high (greater than 40%).
  • Unable to establish if Plant Advanced Technologies's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Plant Advanced Technologies has less than a year of cash runway based on current free cash flow.
  • Plant Advanced Technologies has less than a year of cash runway if free cash flow continues to reduce at historical rates of -20.8% each year.
X
Financial health checks
We assess Plant Advanced Technologies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Plant Advanced Technologies has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Plant Advanced Technologies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Plant Advanced Technologies dividends.
If you bought €2,000 of Plant Advanced Technologies shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Plant Advanced Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Plant Advanced Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ENXTPA:ALPAT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Europe Biotechs Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 0.9%
France Market Average Dividend Yield Market Cap Weighted Average of 324 Stocks 2.9%
France Minimum Threshold Dividend Yield 10th Percentile 0.9%
France Bottom 25% Dividend Yield 25th Percentile 1.6%
France Top 25% Dividend Yield 75th Percentile 4.4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ENXTPA:ALPAT Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31
2018-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Plant Advanced Technologies has not reported any payouts.
  • Unable to verify if Plant Advanced Technologies's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Plant Advanced Technologies's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Plant Advanced Technologies has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Plant Advanced Technologies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Plant Advanced Technologies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Plant Advanced Technologies has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Plant Advanced Technologies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jean-Paul Fevre
COMPENSATION €60,630
AGE 64
CEO Bio

Mr. Jean-Paul Fevre serves as the Chief Executive Officer and Chairman of Plant Advanced Technologies SA.

CEO Compensation
  • Jean-Paul's compensation has increased whilst company is loss making.
  • Jean-Paul's remuneration is lower than average for companies of similar size in France.
Management Team

Jean-Paul Fevre

TITLE
Chairman & Chief Executive Officer
COMPENSATION
€61K
AGE
64

Frederic Bourgaud

TITLE
Vice-Chairman of the Board of Directors & Deputy CEO
COMPENSATION
€12K
AGE
54

Régis Brun

TITLE
Vice-Chairman of the Board of Directors and Deputy Chief Executive Officer
COMPENSATION
€23K
AGE
64

Paul Hannewald

TITLE
Deputy Chief Executive Officer and Director
COMPENSATION
€53K
AGE
38
Board of Directors

Frederic Bourgaud

TITLE
Vice-Chairman of the Board of Directors & Deputy CEO
COMPENSATION
€12K
AGE
54

Régis Brun

TITLE
Vice-Chairman of the Board of Directors and Deputy Chief Executive Officer
COMPENSATION
€23K
AGE
64

Paul Hannewald

TITLE
Deputy Chief Executive Officer and Director
COMPENSATION
€53K
AGE
38

Eric Gontier

TITLE
Director

Jean-Paul Fevre

TITLE
Chairman & Chief Executive Officer
COMPENSATION
€61K
AGE
64

Thierry Fevre

TITLE
Director

Thierry Chapusot

TITLE
Director
AGE
59

Viviane Neiter

TITLE
Director
AGE
60

Michel Salmon

TITLE
Director
TENURE
0.8 yrs

Jean-Yves Ravinet

TITLE
Director
AGE
60
TENURE
0.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Plant Advanced Technologies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Plant Advanced Technologies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Imagine Owning Plant Advanced Technologies (EPA:ALPAT) And Wondering If The 33% Share Price Slide Is Justified

At this point some shareholders may be questioning their investment in Plant Advanced Technologies SA (EPA:ALPAT), since the last five years saw the share price fall 33%. … We don't think Plant Advanced Technologies's revenue of €1,728,129 is enough to establish significant demand? … It seems likely some shareholders believe that Plant Advanced Technologies has the funding to invent a new product before too long.

Simply Wall St -

What Kind Of Shareholder Owns Most Plant Advanced Technologies SA (EPA:ALPAT) Stock?

The big shareholder groups in Plant Advanced Technologies SA (EPA:ALPAT) have power over the company. … With a market capitalization of €17m, Plant Advanced Technologies is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Plant Advanced Technologies

Simply Wall St -

Market Sentiment Around Loss-Making Plant Advanced Technologies SA (EPA:ALPAT)

Plant Advanced Technologies SA's (EPA:ALPAT):. … Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. … Check out our latest analysis for Plant Advanced Technologies

Simply Wall St -

Has Plant Advanced Technologies SA (ENXTPA:ALPAT) Improved Earnings Growth In Recent Times?

Investors with a long-term horizong may find it valuable to assess Plant Advanced Technologies SA's (ENXTPA:ALPAT) earnings trend over time and against its industry benchmark as opposed to simply looking at a sincle earnings announcement at one point in time. … Below is my commentary, albiet very simple and high-level, on how Plant Advanced Technologies is currently performing. … Did ALPAT beat its long-term earnings growth trend and its industry.

Simply Wall St -

Plant Advanced Technologies SA (EPA:ALPAT): Strong Health, Poor Growth

Plant Advanced Technologies SA (ENXTPA:ALPAT) has been on my radar for a while, and the biggest I see is around the sustainability of the business going forward. … Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. … Plant Advanced Technologies has an enviable balance sheet, with high levels of cash generated from its core operating activities (0.49x debt) able to service its borrowings.

Simply Wall St -

Analysts Expect Breakeven For Plant Advanced Technologies SA (EPA:ALPAT)

View our latest analysis for Plant Advanced Technologies According to the industry analysts covering ALPAT, breakeven is near. … ALPAT is therefore projected to breakeven around a couple of months from now! … In order to meet this breakeven date, I calculated the rate at which ALPAT must grow year-on-year.

Simply Wall St -

Company Info

Description

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include PAT Plant Milking that produces active extracts through plant stimulation and living root exudation while preserving plants; PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes; and PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous plants to produce outside their leaf in a sterile closed pitcher. The company was founded in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.

Details
Name: Plant Advanced Technologies SA
ALPAT
Exchange: ENXTPA
Founded: 2005
€15,720,966
970,430
Website: http://www.plantadvanced.com
Address: Plant Advanced Technologies SA
19, avenue de la forêt de Haye,
Vandœuvre-lès-Nancy,
Lorraine, 54500,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA ALPAT Common Stock Euronext Paris FR EUR 05. Aug 2009
Number of employees
Current staff
Staff numbers
35
Plant Advanced Technologies employees.
Industry
Biotechnology
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/21 21:14
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/03/26
Last earnings filing: 2018/10/31
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.